TSN
30
-2
WU
32
2
VFC
53
-3
NOC
45
2
PHM
57
2
DAL
58
-6
TAP
58
-3
FOXA
63
6
TMO
54
-2
ALL
35
-2
MU
35
-7
EBAY
47
3
JNJ
33
-2
NWS
56
-4
MPC
34
-5
PCG
59
3
DIS
77
2
IPG
47
-2
AIZ
68
4
K
53
2
TSN
30
-2
WU
32
2
VFC
53
-3
NOC
45
2
PHM
57
2
DAL
58
-6
TAP
58
-3
FOXA
63
6
TMO
54
-2
ALL
35
-2
MU
35
-7
EBAY
47
3
JNJ
33
-2
NWS
56
-4
MPC
34
-5
PCG
59
3
DIS
77
2
IPG
47
-2
AIZ
68
4
K
53
2
Financhill
Back

Arcus Biosciences 10K Form

Buy
60

RCUS
Arcus Biosciences

Last Price:
16.11
Seasonality Move:
14.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RCUS News And Ratings

See the #1 stock for the next 7 days that we like better than RCUS

RCUS Financial Statistics

Sales & Book Value

Annual Sales: $117M
Cash Flow: $25M
Price / Cash Flow: 0
Annual Sales: $6.17
Price / Book: 2.78

Profitability

EPS (TTM): -3.15000
Net Income (TTM): $-270M
Gross Margin: --
Return on Equity: -46.73%
Return on Assets: -22.44%

Arcus Biosciences Earnings Forecast

Key Arcus Biosciences Financial Ratios

  • The Research & Development expenses have been 290.60% of Revenue.
  • The Interest Expense is -0.65% of Operating Income.
  • The Net Earning history of RCUS is -262.39% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Arcus Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Health Care
Current Symbol: RCUS
CUSIP: 03969F
Website: arcusbio.com

Debt

Debt-to-Equity Ratio: 0.08
Current Ratio: 5.24
Quick Ratio: 5.16

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RCUS Technical Analysis vs Fundamental Analysis

Buy
60
Arcus Biosciences (RCUS) is a Buy

Is Arcus Biosciences a Buy or a Sell?

  • Arcus Biosciences stock is rated a Buy
    The current Arcus Biosciences [RCUS] share price is $17.16. The Score for RCUS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.